A strategic approach to bringing CiRPCs technology to patients, starting with orphan diseases and expanding to address the global burden of retinal degeneration.
Our pipeline prioritizes rapid clinical translation while building a platform for addressing multiple retinal degenerative diseases.
Orphan Drug Designation: Targeting this rare but devastating inherited condition provides regulatory advantages and accelerated development pathways.
RP affects approximately 2 million people worldwide with no current cure. Our CiRPCs technology offers the first potential treatment to restore lost vision.
Largest Market: The leading cause of blindness in patients over 60, affecting over 200 million people worldwide with no current treatment for the dry form.
Our RP clinical data will support expansion into this massive underserved population, leveraging established safety and efficacy profiles.
Global Health Priority: Affecting 93 million people worldwide, disproportionately impacting underserved populations in developing countries.
Advanced diabetic retinopathy leads to irreversible vision loss when current treatments fail. Our technology offers hope for restoration even in advanced cases.
A clear roadmap from preclinical success to patient treatment, with key regulatory and clinical milestones.
Complete GMP manufacturing, toxicology studies, and regulatory preparations for RP clinical trial authorization.
Submit IND application for RP program. Leverage orphan drug designation for expedited review and development incentives.
Initiate Phase I/II clinical trial for RP patients. Focus on safety, tolerability, and preliminary efficacy signals.
Initiate IND-enabling studies for dry AMD program. Begin planning for diabetic retinopathy development pathway.
Multiple programs in clinical development, establishing CiRPCs as the leading platform for retinal regeneration therapy.
Leveraging orphan drug advantages and established regulatory pathways for cell therapy development.
Our pipeline represents more than scientific milestones—it's a roadmap to transforming millions of lives. Partner with us to make vision restoration a reality.